Market Overview

PDL BioPharma, Inc. (NASDAQ: PDLI)

2.87 +0.01 (0.35%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2019
After-Hours
EPS:
REV:
0.01
38.518M



Q4 2018
After-Hours
EPS:
REV:
0.16
68.036M



Q3 2018
After-Hours
EPS:
REV:
0.14
62.749M



Q2 2018
After-Hours
EPS:
REV:
0.26
143.835M



Q1 2018
After-Hours
EPS:
REV:
0.04
45.44M
0.06
50.4M
0.01
38.518M
-83.33%
-23.58%
Q4 2017
After-Hours
EPS:
REV:
-0.05
66.492M
0.11
59.95M
0.16
68.036M
45.45%
13.49%
Q3 2017
After-Hours
EPS:
REV:
0.11
53.628M
0.13
61.86M
0.14
62.749M
7.69%
1.44%
Q2 2017
After-Hours
EPS:
REV:
0.09
21.047M
0.09
56.3M
0.26
143.835M
188.89%
155.48%
Q1 2017
After-Hours
EPS:
REV:
0.52
130.226M
0.05
50.23M
0.08
45.44M
60%
-9.54%
Q4 2016
After-Hours
EPS:
REV:
0.61
178.058M
0.09
56.37M
-0.05
66.492M
-155.56%
17.96%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!